Table 1 pH, water retention, swelling ratio, and porosity studies of different formulations.

From: Synthesis and characterization of Hyaluronic Acid (HA) modified polymeric composite for effective treatment of wound healing by transdermal drug delivery system (TDDS)

Trials

Chitosan (%)

Hyaluronic acid (%)

pH

% water retention

% swelling ratio

% porosity

% drug release

Fl

1.5

0.2

5.44 ± 0.07

23.07 ± 0.10

108.75 ± 0.56

67.5 ± 0.45

70.84 ± 0.06

F2

1.0

0.2

5.3 ± 0.03

26.60 ± 0.34

87.50 ± 0.57

59.6 ± 0.87

90.59 ± 0.07

F3

1.0

0.3

5.33 ± 0.01

18.36 ± 0.24

81.25 ± 0.37

50.6 ± 0.28

71.69 ± 0.09

F4

1.0

0.4

5.69 ± 0.08

13.04 ± 0.12

68.75 ± 0.67

48.4 ± 0.56

64.51 ± 0.02

F5

1.0

0.5

5.74 ± 0.05

12.04 ± 0.45

62.50 ± 0.26

42.0 ± 0.34

81.04 ± 0.05

F6

0.5

0.2

5.48 ± 0.04

10.11 ± 0.31

48.75 ± 0.56

37.8 ± 0.12

64.78 ± 0.07

F7

0.5

0.3

5.52 ± 0.06

8.04 ± 0.13

41.25 ± 0.64

36.2 ± 0.25

86.49 ± 0.09

F8

0.5

0.4

5.63 ± 0.04

6.97 ± 0.25

37.5 ± 0.59

33.8 ± 0.42

71.97 ± 0.04